The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19. - Hernández-Blanco C; Al-Akioui-Sanz K; Herrera L; Aguirre-Portolés C; Lozano-Ojalvo D; Pérez-Rodriguez L; Cano-Ochando J; Guerra-García P; Martín-Quirós A; Vicario JL; Santos S; Pérez-Vaquero MÁ; et al. (IScience, 2024)